Visuomotor behaviour – from handling simple objects to operating complex devices – is of fundamental importance in our everyday lives, yet there is relatively little evidence as to how healthy ageing affects these processes. A central role is played by the human capacity for reaching and grasping. Grasping an object requires complex visuomotor transformations, including processing of the object’s extrinsic features (it’s spatial location) and intrinsic features (such as size and shape). It has been documented that action relevant intrinsic object properties automatically facilitate specific motor actions despite being task-irrelevant, the so-called object affordance effect. These effects have been demonstrated for (1) grasp type (precision and power grips being facilitated by small and large objects) and (2) object-orientation (whereby right and left handed grasps are facilitated by object-orientation), and might underlie the effortlessness with which humans can interact with objects. Yet, these paradigms have not previously been employed in the study of healthy ageing, and little is known concerning how these processes change over the life span. Elucidating these changes is of particular importance as age-related degeneration of white matter integrity is well documented. Consequently, if successful visuomotor behaviour relies on white matter integrity, age-related reductions in affordance effects should be observed. This prediction was tested in a series of experiments. Experiment 1 investigated age-differences in object-size compatibility effects, and results corroborated our prediction of age-related reductions in object-size effects. Experiment 2 investigated age-differences in (1) spatial compatibility effects versus object-orientation effects, and (2) the locus of the effects (facilitation versus interference effects). Results revealed (1) some evidence of larger affordance than spatial effects in both age-groups, and (2) interference effects in the younger group and both facilitation and interference effects in the older group, showing a potential change in processing modes or strategies. Experiments 3 and 4 addressed the main competing account, the attention-directing hypothesis (according to which attentional shifts are responsible for the generation of automatic response codes, rather than the affects arising from afforded actions), by using a novel stimulus set in which such attentional differences can be ruled out. Results provided strong evidence in favour of the object-size affordance hypothesis. A final neuroimaging experiment investigated age-differences in the object-size effect and its neural correlates by combining behavioural, functional MRI and diffusion tensor imaging (DTI) data. Results revealed evidence of age-differences, both on the behavioural and functional level. For the DTI data, we investigated all four diffusion metrics (something which is not frequently reported in the healthy ageing literature), and found widespread age-related differences in white matter integrity. The empirical findings presented in this thesis offer a significant contribution to ageing research, by further elucidating the relationship between age-related neurophysiological changes and visuomotor behaviour. The overall picture which emerged from this series of experiments was consistent with our prediction of age-related reductions in affordance effects. Furthermore, it is likely that these age-differences may have, at least in part, a neurophysiological basis.

L'érythropoiétine (Epo) est une protéine ubiquitaire dans les tissus de l'organisme. Elle est dotée d'une fonction endocrine, autocrine et paracrine. Elle favorise les activités anti-apoptotiques des tissus soumis à un stress hypoxique. Dans de nombreux modèles animaux de traumatisme ou d'agression du système nerveux central et quelques études cliniques, l'Epo recombinante humaine (Epo-rh) a révélé des propriétés neuroprotectrices. L'objectif principal de ce travail est d'améliorer les connaissances sur l'Epo afin de favoriser l'inclusion de l'Epo-rh dans l'arsenal thérapeutique chez l'homme après traumatisme du système nerveux central. Deux axes de travail ont été explorés : dans un première partie, pour expliquer l'échec de la mise en oeuvre d'une étude de la tolérance et d'efficacité biologioque de l'Epo-rh dans le Traumatisme Médullaire Déficitaire (TMD) chez l'homme, nous avons étudié l'épidémiologie des TMD sur la période 1997-2006, à partir du Registre des accidents du Rhône. Ensuite nous avons étudié l'évolution de cette incidence entre 2 périodes de 6 ans : 1995-2001 et 2003-2008. Parallèlement, compte tenu d'une incidence de traumatisme crânien (TC) 20 fois plus élevée que celle du TMD chez l'homme, nous avons entrepris de caractériser les effets d'un TC expérimental par percussion fluide latérale (LFPI) chez le rat afin de mieux comprendre la pharmacologie et les mécanismes d'action moléculaires, en particulier anti-inflammatoires et neuroprotecteurs, de l'Epo-rh / Erythropoietin (Epo) is an ubiquitous cytokine. It has endocrine, paracrin and autocrin functions. It improves antiapoptotic mechanisms on all tissues subjected to hypoxic stress. In many animal models of brain trauma but also in other brain injury models, and some human clinical studies, recombinant Human Epo (Epo-rh) has proven neuro-protective properties. The main goal of this work was to improve and incorporate Epo-rh in the pharmacological arsenal of treatment in brain and spinal cord traumatic injuries in human. In a first part, to explore the reasons of failure of inclusion in a Spinal Cord Injury (SCI) study to test the thrombo-embolic tolerance and efficacy of Epo-rh, we studied the epidemiology of SCI using the road crash Rhône registry in the period 1997-2006. Then we compared the epidemiological trends of the SCI incidence, associated trauma, mortality and fatality rates in two periods of 6 years: 1995-2001 and 2003-2008. In a second part, due to the 20-fold higher incidence of traumatic brian injury (TBI) in comparison to SCI, we characterized the effects of a moderate (1.6-1.8 atm) lateral fluid percussion injury (LFPI) in order to understand and characterize the pharmacological, anti-inflammatory and neuroprotective mechanisms of action of Epo-rh in such a brain injury